Refine your search
Collections
Co-Authors
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Chaturvedi, Rekha
- Impact of TRIPS on Providing Easy Access to Affordable Medicines in India
Abstract Views :119 |
PDF Views:57
Authors
Affiliations
1 Cluster Innovation Centre, University of Delhi, Delhi-110007, IN
1 Cluster Innovation Centre, University of Delhi, Delhi-110007, IN
Source
Journal of Intellectual Property Rights, Vol 22, No 5 (2017), Pagination: 257-265Abstract
Trade Related Aspects of Intellectual Property Rights (TRIPS) Agreement affected on 1st January 1995 have provided minimum standards for protecting nearly all forms of intellectual property. Product patents were introduced in pharmaceuticals sector in the amended Indian Patent Act (1970) to make it TRIPS compliant. Many eminent IP experts from industry, academia, policy makers, IP practitioners, government officials and regulatory personnel had expressed concern about increase in drug prices, discouragement in R&D, limited manufacturing of drugs and restriction of competition that may impact the access to drugs and new technologies. To curtail the possible adverse impact of patents on access to medicines, flexibilities have been provided in the TRIPS Agreement. These include certain provisions of Indian Patent Act such as compulsory licensing (Section 84), restriction on grant of patent for new use of a known substance as well as for new forms unless they exhibit significant efficacy (Section 3d) and provision of two-tier patent opposition i.e pre-grant and post-grant opposition [(Section 25 (1) and 25 (2)]. Implementation of these provisions has improved access to drugs to some extent in the post-TRIPS era. There are certain regulations concerning interests of the public with which the Government also controls the drug price and the access of drugs to the public. Drug Price Control Order (DPCO) controls price of the drugs in India. The Government has also raised the ambit of DPCO to include all the drugs in the National List of Essential Medicines (NLEM) including the combination drug where one or more drugs fall under NLEM. The procedure for calculating the ceiling price of the drugs has been changed from a cost based approach to a market based approach. Further, an external reference pricing system has been suggested by the National Pharmaceutical Pricing Authority (NPPA) to negotiate the prices of patented medicines so that availability of drugs improves. Keeping several factors into consideration that exerts influence on the drug prices that in turn have a direct effect on the access to medicine to the Indian public, this article mainly discusses the impact of TRIPS on the specific sections of the Indian Patent Act based on flexibilities provided by TRIPS to the developing countries. Contribution of the pharmaceutical industry, the Indian Government, research-based multinational drug companies, medical professionals, drug research policy, drug production, drug pricing on access to medicines is also discussed.Keywords
TRIPS, WHO, DPCO, Patent, Generic Drug, Compulsory License, Drug, Pharmaceutical Company.References
- WHO, Intellectual Property Rights and Access to Medicines: A South-East Asia perspective on global issues, (2008), http://www.searo.who.int/entity/intellectual_property/trh.pdf.
- Nair M D, Impact of emerging IPR regime on India pharmaceutical industry, National Intellectual Property Organization Souvenir, 2004, p. 29.
- Nair M D, TRIPS and access to affordable drugs, Journal of Intellectual Property Rights, 17 (7) (2012) 305-314.
- Donoso E A, Global Solution for the Protection of Inventions, 2014, http://pdf-directory.org/ebook.php?id=a51nAwAAQBAJ.
- WTO OMC FACT SHEET, TRIPS and pharmaceutical patents, 2006, https://www.wto.org/ENGLISH/ tratop_e trips_e/tripsfactsheet_pharma_2006_e.pdf.
- World Health Assembly, Resolution WHA28.66, Geneva, World Health Organization, 1975.
- Laing R, Waning B, Gray A, Ford N & Hoen E, 25 years of the WHO essential medicines lists: Progress and challenges, R - The Lancet, 361 (5) (2003) 1723-1729.
- Sinha K, Govt. to bring essential medicines under price control, Times of India, 28 September 2012, http://articles.timesofindia.indiatimes.com/2012-09-28/india/34147534_1_price-controlnlem-essential-medicines.
- NLEM, 2011, http://pharmaceuticals.gov.in/pdf/NLEM.pdf.
- Kumar R S P, Balamuralidhara V, Kumar P T M & Dave A J, Need for drug price control in India, Adv J Pharm Life Sci Res, 1 (1) (2013) 22-30.
- What are Neglected Diseases?, News Medical, 2011, http://www.newsmedical.net/health/what-are-neglected-diseases.aspx (accessed on 27 October 2016).
- Neglected Tropical Diseases, World Health Organization (WHO), 2013, http://www.who.int/neglected_diseases/en/ (accessed on 27 October 2016).
- Bors C, Christie A, Gervais D & Clayton E W, Improving access to medicines in low-income countries: A review of mechanisms, The Journal of World Intellectual Property, 18 (1-2) (2015) 1-28.
- Vacca R, Intellectual Property and Public Health - A White Paper, Akron Research Paper No. 13-11, School of Law, University of Akron, 2013.
- Cameron A, Ewen M, Ross-Degnan D, Ball D & Laing R, Medicine prices availability and affordability in 36 developing middle-income countries: A secondary analysis, The Lancet, 373 (2009) 240-49.
- Drug Spending in OECD Countries Up by Nearly a Third Since 1998, According to New OECD Data, Organization for Economic Co-operation and Development, 2005, http://www.oecd.org/general/drugspendinginoecdcountriesupbynearlyathirdsince1998accordingtonewoecddata.htm.
- The World Medicines Situation, WHO, 2004, http://apps.who.int/ medicinedocs/pdf/s6160e/s6160e.pdf, (accessed on 27 October 2016).
- Health Expenditure Per Capita, World Bank, 2014, http://data.worldbank.org/indicator/SH.XPD.PCAP.
- Business News, 26 February 2016, http://www.firstpost. com/business/budget-2016-healthcare-cannot-wait-mr-jaitley-healthy-india-can-hasten-wealthy-india-2644650.html.
- WHO National Health accounts, Global Health Expenditure Database, http://www.who.int/health-accounts/ghed/en/.
- Annual Report, MHFW, December 2011, http://www.mohfw.nic.in/showfile.php?lid=121.
- Niens L M, Cameron A, Van D P E, Brouwer W B F & Laing R, Quantifying the impoverishing effects of purchasing medicines: A cross-country comparison of the affordability of medicines in the developing world, PLoS Medicine, 7 (8) (2010), e1000333. doi: 10.1371/journal.pmed.1000333.
- Greene W, The emergence of india’s pharmaceutical industry and implications for the U.S. generic drug market, Office of Economics Working Paper U.S. International Trade Commission, 2007, https://www.usitc.gov/publications/332/EC200705A.pdf.
- TRIPS Agreement, https://www.wto.org/english/docs e/legal_e/27-trips.pdf.
- Implications of the Doha Declaration on the TRIPS Agreement and Public Health WHO, 2002, http://apps.who.int/medicinedocs/pdf/s2301e/s2301e.pdf.
- Ellen F M & Hoen T TRIPS, Pharmaceutical patents and access to essential medicines: Seattle, Doha and beyond, 2003, http://www.who.int/intellectualproperty/ topics/ip/tHoen.pdf.
- Arora S & Chaturvedi R, "Section 3 (d): Implications and key concerns for pharmaceutical sector, Journal of Intellectual Property Rights, 21 (2016) 16-26.
- Amended Indian Patent Act, 2005, http://www.ipindia.nic.in/.
- The Value of Incremental Pharmaceutical Innovation, U.S-India Business Council, 2009, http://www.indiaenvironmentportal.org.in/files/USIBCIncrementalInnovationReport Final.pdf (accessed on 20 November 2016).
- Rodriguez V, Patent pools: Intellectual property rights and competition, Open AIDS Journal, 4 ( 2010) 62-66.
- Nair G G, Fernandes A & Nair K, Landmark pharma patent jurisprudence in India, Journal of Intellectual Property, 14 (2014) 79-88.
- 558/DELNP/2003, Crystalline Tiotropium Bromide Monohydrate and Process Thereof, http://ipindiaservices.gov.in/decision/00558-DELNP-2003-9637/ 558-delnp-2003%2025(2)%20decision.pdf (accessed on 25 September 2016).
- Gopakumar K M, Product patents and access to medicines in India: A critical review of the implementation of TRIPS patent regime, The Law and Development Review, 3 (2) (2010) Art. 11.
- Nair G G & Fernandes A, Patent policies and provisions relating to pharmaceuticals in India, Journal of Intellectual Property Rights, 19 (1) (2014) 7-17.
- Ramani S V & Urias E, Access to critical medicines: When are compulsory licenses effective in price negotiations? Social Science & Medicine, 135 (6) (2015) 75-83.
- Kaur A & Chaturvedi R, Compulsory licensing of drugs and pharmaceuticals: Issues and dilemma, Journal of Intellectual Property Rights, 20 (9) (2015) 279-287.
- WHO/TCM/2005, Remuneration guidelines for non-voluntary use of a patent on medical technologies, http://www.who.int/hiv/amds/WHOTCM2005.1_OMS.pdf.
- Kochhar R, Indian pharmaceutical industry: Policies, achievements and challenges, Current Science, 106 (10) (2014) 1345.
- Hirschler B, Bayer fails to block generic cancer drug in India‟s top court, Reuters, 2014, http://in.reuters.com/article/2014/12/12/us-bayer-indiaruling-idINKBN0JQ1XA20141212.
- Hoffman S J & So K, Assessing 15 proposals for promoting innovation and access to medicines globally for the global access to medicines, Reform Study Team Ann Glob Health, 80 (6) (Nov-Dec 2014) 432-43.
- Bermudez J & 't Hoen E, The UNITAID patent pool initiative: Bringing patents together for the common good, Open AIDS J, 4 (2010) 37-40.
- Clark J, Patent pools: A solution to the problem of access in biotechnology patents? 2000, www.uspto.gov/web/offices/pac/dapp/opla/patentpool.pdf, (accessed on 27 October 2016).
- Danzon P M & Towse A, Differential pricing for pharmaceuticals: Reconciling access, R&D and patents, International Journal of Health Care Finance and Economics, 3 (2003)183-205.
- Wheeler C & Berkley S, Initial lessons from public-private partnerships in drug and vaccine development Bulletin of the World Health Organization, 79 (8) (2001) 728.
- Golechha M, Healthcare agenda for the Indian government, Indian J Med Res, 141 (10) (2015) 151-153.
- Golechha M, The National Health Assurance Mission for India, 384 (9949) (11) (2016) 1185-1186.
- High level expert group report on universal health coverage for India, Planning Commission of India, 2011, http://planningcommission.nic.in/reports/genrep/rep_uhc0812.pdf, (accessed on 6 November 2016).
- Basant R & Srinivasan S, Intellectual Property Protection in India and Implications for Health Innovation: Emerging Perspectives, No. WP2015-04-01,Indian Institute of Management Ahmedabad, Research and Publication Department, 2015.
- Lalitha N, Tamil Nadu Government intervention and prices of medicines, Economic and Political Weekly, 2008, 66-71.
- Nautiyal S, IMA to promote affordable and efficacious branded generics through Nirmalaya, (2015), http://www.pharmabiz.com/NewsDetails.aspx?aid=86804&sid=1, (accessed on 20 November 2016).
- Copyright Protection in the Digital Environment: Indian Perspective and International Obligations
Abstract Views :109 |
PDF Views:32
Authors
Affiliations
1 Cluster Innovation Centre, University of Delhi, Delhi -110 007, IN
1 Cluster Innovation Centre, University of Delhi, Delhi -110 007, IN
Source
Journal of Intellectual Property Rights, Vol 22, No 6 (2017), Pagination: 303-310Abstract
With the advancement in the digital technology, the distribution of the copyrighted material on the internet has brought about a drastic change in the pre-existing laws. Unfair use and illegal downloading of copyrighted material such as software, videos, songs etc. have developed into a major problem in the digital domain. To overcome these problems several technological and legal measures have been taken up such as development of tools like Encryption, Digimarc, Watermark, besides framing of various international treaties and agreements including TRIPS, Anti-counterfeiting trade agreement (ACTA), WIPO Copyright Treaty (WCT), WIPO Performance and Phonogram Treaty (WPPT) etc. Indian Copyright Act after amendment of 2012 seems to be effective enough to resolve the issues concerned with infringements in the digital domain hence debate is going on if India should sign WCT and WPPT and the matter is still under consideration of the Government of India. The development in the digital environment has altered the boundaries for the copyright holders to look at the protection of copyrighted material through various techniques. The present article deliberates about the Indian Copyright Act, various international copyright treaties, limitations and exceptions provided by TRIPS and also looks towards the usefulness of various treaties available for the digital domain. Furthermore, steps to control the misuse of copyrighted material are also discussed. The article concludes with some suggestions and ideas that could be useful for regulating the unfair use and illegal downloading of the copyrighted material.Keywords
WIPO, TRIPS, Indian Copyright Act, WCT, WPPT, Digital Rights Management (DRM), Rights Management Information (RMI), Berne Convention.References
- Indian Copyright ACT 1957 as amended in 2012.
- http://economictimes.indiatimes.com/definition/piracy (accessed on 5 November 2016).
- http://brandongaille.com/34-startling-internet-piracystatistics (accessed on 24 October 2016).
- The Congress of the United States, Congressional Budget Office, Copyright Issues In Digital Media, https://www.cbo.gov/sites/default/files/108th-congress-20032004/reports/08-09-copyright.pdf (accessed on 11 September 2016).
- http://whatis.techtarget.com/definition/piracy (accessed on 1 November 2016.
- Proserpio L, Salvemini S & Ghiringhelli V, Entertainment pirates: Determinants of piracy in the software, International Journal of Arts Management, 81 (2005) 33-47. http://www.wipo.int/treaties/en/ip/phonograms/summary_phonograms.html (accessed on 2 September 2016).
- Cole A T, International Copyright Law, Part I: The Berne Convention for the Protection of Literary and Artistic Works, 1886, 1-34.
- http://www.wipo.int/treaties/en/ip/beijing/summary_beijing.h tml (accessed on 27 August 2016).
- http://www.wipo.int/treaties/en/ip/phonograms/summary_ph onograms.html (accessed on 2 September 2016).
- http://www.wipo.int/treaties/en/ip/phonograms/summary_ph onograms.html (accessed on 2 September 2016).
- Diplomatic Conference to Conclude a Treaty to Facilitate Access to Published Works by Visually Impaired Persons and Persons with Print Disabilities, World Intellectual Property Organization, 2013.
- http://www.wipo.int/treaties/en/ip/marrakesh/summary_mar rakesh.html (accessed on 5 September 2016).
- http://www.wipo.int/treaties/en/ip/rome/summary_rome.html (accessed on 8 September 2016).
- http://www.wipo.int/treaties/en/ip/wct/summary_wct.html (accessed on 10 September 2016).
- http://www.wipo.int/treaties/en/ip/wppt/summary_wppt.html (accessed on 12 September 2016).
- http://www.mofa.go.jp/policy/economy/i_property/pdfs/acta 1105_en.pdf (accessed on 23 September 2016).
- http://www.wipo.int/treaties/en/text.jsp?file_id=295166 (accessed on 22 August 2016).
- Facelift for the Indian Copyright Act, 14 (2010).
- Report by World Intellectual Property Organization, Geneva, 3rd Session, The Digital Agenda: Implementation of the WIPO Copyright Treaty (WCT) and the WIPO Performances and Phonograms Treaty (WPPT), 28 October-1 November 2002, http://www.wipo.int/export/sites/www/ copyright/en/activities/pdf/advantages_wct_wppt.pdf (accessed on 22 November 2016).
- Thomas Z, Overview of changes to the Indian Copyright Law, Journal of Intellectual Property Rights, 17 (2012) 324-334.
- Dean S M & Bruce H T, Workshop on implementation issues of the WIPO Copyright Treaty (WCT) and the WIPO Performances and Phonograms Treaty (WPPT), Law and Commercial Licenses, 1999, 6-7.
- The advantages of adherence to the WIPO Copyright Treaty (WCT) and the WIPO Performances and Phonograms Treaty (WPPT), document prepared by the International Bureau of WIPO.
- Rafiqi F A & Bhat I H, Copyright protection in digital environment: Emerging issues, International Journal of Humanities and Social Science Invention, 2 (4) (2013) 2319-7722.
- James T C, Digital technology and Libraries: A Copyright approach, Annals of Library and Information Studies, 52 (1) (2005) 1-7.
- Zingales N, Digital copyright, “Fair access” and the problem of DRM misuse, Boston College Intellectual Property & Technology Forum, 2012, 1-36.
- http://cs.furman.edu/digitaldomain/themes/copyrights/copyri ght4.html (accessed on 31 August 2016).
- Scaria A G, Does India need digital right management provision or better digital business management strategies, Journal of Intellectual Property Rights, 17 (2012) 463-477.
- Verma S K, IP Protection of Software and Software Contracts in India: A Legal Quagmire, Journal of Intellectual Property Rights, 17 (2012) 284-295.
- Pamela S & Scotchmer S, DRM technologies by Information industries and the subsequent circumvention of those technologies, Yale Law Journal, 111 (7) (2002) 1631-1633.